Financials YSB Inc.

Equities

9885

KYG9879S1003

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:17 2024-05-17 am EDT 5-day change 1st Jan Change
8.25 HKD -0.96% Intraday chart for YSB Inc. -0.48% +0.12%

Valuation

Fiscal Period: December 2023
Capitalization 1 4,797
Enterprise Value (EV) 1 3,177
P/E ratio -0.91 x
Yield -
Capitalization / Revenue 0.28 x
EV / Revenue 0.19 x
EV / EBITDA -193 x
EV / FCF -511,694 x
FCF Yield -0%
Price to Book 2.49 x
Nbr of stocks (in thousands) 640,486
Reference price 2 7.489
Announcement Date 4/19/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 6,065 10,094 14,275 16,972
EBITDA 1 -267.4 -371.6 -203.2 -16.44
EBIT 1 -301.7 -415.4 -259.2 -70.02
Operating Margin -4.97% -4.12% -1.82% -0.41%
Earnings before Tax (EBT) 1 -576.3 -503.1 -1,497 -3,210
Net income 1 -571.7 -494 -1,489 -3,189
Net margin -9.43% -4.89% -10.43% -18.79%
EPS 2 -4.562 -3.942 -11.88 -8.260
Free Cash Flow - 908.4 1,709 -6,210
FCF margin - 9% 11.97% -36.59%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 6/1/23 6/1/23 6/1/23 4/19/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - -
Net Cash position 1 302 959 1,686 1,619
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - 908 1,709 -6,210
ROE (net income / shareholders' equity) - 18.7% 41.2% 258%
ROA (Net income/ Total Assets) - -8.61% -4.29% -0.94%
Assets 1 - 5,735 34,675 339,603
Book Value Per Share 2 -19.60 -23.10 -34.70 3.010
Cash Flow per Share 2 1.040 3.060 6.670 1.060
Capex 1 22.4 67 38.8 17.2
Capex / Sales 0.37% 0.66% 0.27% 0.1%
Announcement Date 6/1/23 6/1/23 6/1/23 4/19/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW